# Effects of ATF2/TSC1 on epilepsy by modulating the microphages polarization of microglia

**Authors:** Wenjiao Huang, Wenli Chen, Zhong Zhao, Lingchun Liu, Yuanyuan Zhao, Xinzhang Chen, Rong Li

PMC · DOI: 10.1038/s41598-025-04914-4 · 2025-07-02

## TL;DR

This study explores how ATF2 and TSC1 affect epilepsy by influencing microglia inflammation, suggesting new treatment approaches.

## Contribution

The study reveals a novel regulatory mechanism involving ATF2 and TSC1 in microglia polarization during epilepsy.

## Key findings

- ATF2 promotes M1 microglia polarization and increases pro-inflammatory cytokines in epilepsy models.
- TSC1 overexpression reduces M1 polarization and neuroinflammation in KA-induced models.
- ATF2 negatively regulates TSC1 transcription by binding to its promoter region.

## Abstract

Epilepsy (EP) is a chronic nervous system disease characterized by recurrent attacks, and its causes are complicated. Inflammatory reaction mediated by microglia is an important factor in the progression of EP. Activating transcription factor 2 (ATF2) can be used as a transcription factor to regulate the microglia-mediated inflammatory response, but its role in EP is unclear. In this study, kainic acid (KA) was used to induce the EP cell and mouse model. Real-time polymerase chain reaction was used to detect ATF2, TNF-α, IL-6, TGF-β, and IL-10 mRNA expression. ATF2, INOS, ARG1, and TSC1 protein levels was examined by western blot. The fluorescence intensity of ATF2, IBA1, CD80, and CD206 was examined by immunofluorescence staining. The cell ratios of CD80, IL-1β, CD206, and CD63 were detected by flow cytometry. Dual-luciferase reporter and chromatin immunoprecipitation assays were conducted to verify the interaction between ATF2 and TSC1. Hematoxylin & eosin and Nissl staining were used to observe the structure of hippocampus and Nissl bodies. The results indicated that KA induced M1 polarization of HMC3 cells and increased the levels of TNF-α and IL-6 mRNA by activating KA receptors, and inhibiting KA receptors attenuated the M1 polarization of KA-induced HMC3 cells. ATF2 expression was increased in KA-induced HMC3 cells and hippocampal tissues of mouse, while TSC1 expression was repressed. ATF2 knockdown diminished the M1 polarization of KA-induced HMC3 cells, enhanced the M2 polarization, and relieved neuroinflammation in EP mouse. TSC1 overexpression inhibited M1 polarization in KA-induced HMC3 cells. Dual luciferase and chromatin immunoprecipitation results revealed that ATF2 bound to the promoter of TSC1 and negatively regulated the transcription of TSC1. In conclusion, inhibition of ATF2 and promotion of TSC1 transcription may be a new pathophysiological mechanism for the treatment of EP neuroinflammation.

The online version contains supplementary material available at 10.1038/s41598-025-04914-4.

## Linked entities

- **Genes:** ATF2 (activating transcription factor 2) [NCBI Gene 1386], TSC1 (TSC complex subunit 1) [NCBI Gene 7248], TNF (tumor necrosis factor) [NCBI Gene 7124], IL6 (interleukin 6) [NCBI Gene 3569], TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040], IL10 (interleukin 10) [NCBI Gene 3586], NOS2 (nitric oxide synthase 2) [NCBI Gene 4843], ARG1 (arginase 1) [NCBI Gene 383], IL1B (interleukin 1 beta) [NCBI Gene 3553], CD80 (CD80 molecule) [NCBI Gene 941], MRC1 (mannose receptor C-type 1) [NCBI Gene 4360], CD63 (CD63 molecule) [NCBI Gene 967], AIF1 (allograft inflammatory factor 1) [NCBI Gene 199]
- **Chemicals:** kainic acid (PubChem CID 3816)
- **Diseases:** epilepsy (MONDO:0005027)

## Full-text entities

- **Genes:** CD63 (CD63 molecule) [NCBI Gene 967] {aka AD1, HOP-26, ME491, MLA1, OMA81H, Pltgp40}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, IL10 (interleukin 10) [NCBI Gene 3586] {aka CSIF, GVHDS, IL-10, IL10A, TGIF}, ISYNA1 (inositol-3-phosphate synthase 1) [NCBI Gene 51477] {aka INO1, INOS, IPS, IPS 1, IPS-1}, ARG1 (arginase 1) [NCBI Gene 383], ATF2 (activating transcription factor 2) [NCBI Gene 1386] {aka CRE-BP1, CREB-2, CREB2, HB16, TREB7}, MRC1 (mannose receptor C-type 1) [NCBI Gene 4360] {aka CD206, CLEC13D, CLEC13DL, MMR, MRC1L1, bA541I19.1}, CD80 (CD80 molecule) [NCBI Gene 941] {aka B7, B7-1, B7.1, BB1, CD28LG, CD28LG1}, AIF1 (allograft inflammatory factor 1) [NCBI Gene 199] {aka AIF-1, IBA1, IRT-1, IRT1}, IL1B (interleukin 1 beta) [NCBI Gene 3553] {aka IL-1, IL1-BETA, IL1F2, IL1beta}, TSC1 (TSC complex subunit 1) [NCBI Gene 7248] {aka LAM, TSC}, TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040] {aka CAEND1, CED, DPD1, IBDIMDE, LAP, TGF-beta1}
- **Diseases:** Inflammatory (MESH:D007249), nervous system disease (MESH:D009422), EP (MESH:D004827), neuroinflammation (MESH:D000090862)
- **Chemicals:** eosin (MESH:D004801), Nissl (-), Hematoxylin (MESH:D006416), KA (MESH:D007608)
- **Species:** Mus musculus (house mouse, species) [taxon 10090]
- **Cell lines:** HMC3 — Homo sapiens (Human), Transformed cell line (CVCL_II76)

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12214619/full.md

---
Source: https://tomesphere.com/paper/PMC12214619